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ABSTRACT
Research by the authors and expert opinion obtained from interview and questionnaire
response predict the availability of an acceptable artificial heart for use in humans, and the
development of proper medical procedures for its installation, within the next 15 to 20 years.
Present medical advances are reducing the number of heart problems solvable by artificial-
heart implantation, but, because of increasing population, the actual number of those
needing this operation may not decrease.
Application of a least-squares straight-line trend to the present number of physicians
in the United States leads to an increase in future numbers of physicians which is not quite
equal to the population increase. However, with the relative simplicity of this type of
operation compared to other heart operations, the availability of highly specialized "heart-
care medical centers, and the provision of several supporting surgical teams per physician,
heart-implant operations should be available to all who need them. Such operations would
not be cheap (estimated to cost $5-6,000 for the artificial heart and $5-50,000 for the im-
plantation), but this should not deter use of the operation when survival is at stake.
Given the availability of a reliable artificial heart, its successful use in mankind appears
extremely optimistic if the required planning and research are performed.
INTRODUCTION
Modern methods of forecasting technology and resultant predictions have made
possible more effective long-range planning and analysis and also better adapta-
tion to conditions which deviate from forecasts and plans. The important con-
tribution of forecasting technology is that it makes possible identification and
estimation of trends toward future conditions, such as projected demand for and
projected availability of financial resources, facilities, and manpower. These
estimates provide the basis for advance planning, which facilitates the more rapid
and effective application of the results of research toward and development of the
artificial heart. Such an artificial heart is predicted to become available within
the next two decades, despite the many problems yet to be solved through research
and development.
Heart disease today claims some 700,000 to 1,000,000 Americans yearly, accord-
ing to both Colenpaul (1971) and Harmison (1972). Estimates vary as to how
many or what percent of heart-disease deaths could have been avoided or post-
poned by utilization of an artificial heart. Cooper (1972) estimated that from
10,000 to 100,000 Americans might be potential candidates for artificial hearts
when they become available; Harmison (1972) has estimated the demand to be
between 15,000 and 100,000. The authors of this paper recognize that mortality
statistics are primarily an estimate at the present time, but such statistics still
provide a starting point for this analysis. It is also recognized that the estimated
demand (by Cooper, 1972, and by Harmison, 1972) for an artificial heart might
be vastly overestimated, but it is proposed that there is and will continue to be a
very real and significant demand for an artificial heart. The fact that this demand
Results of original research were first presented at the combined meeting of the Ohio
Academy of Science and the Ohio Academy of Medical History, History of Science Meeting,
Columbus, Ohio, April 1972.
2Manuscript received December 8, 1972.3The two nonmedically trained authors believed that the viewpoint of a thoracic surgeon
was required to evaluate the validity of the premises and research findings. Dr. Vasko pro-
vided this input and agreed to be listed as a coauthor. In order to identify his medical views,
in contrast to the views of the two nonmedical authors, Dr. Vasko's name is used in the text
with his contributions.
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cannot presently be stated with a high degree of certainty should not be used as a
basis for not considering and understanding the nature of the factors necessary
for the timely and effective utilization in man of an artificial heart, when it is
available.
Information about the actual research and development of the artificial heart
itself is not analyzed in this paper. This paper reviews and analyzes the factors
basic to the planning and control of a program designed to insure timely and
effective utilization of artificial hearts by mankind.
RESEARCH METHODS
Research for this paper was begun by reviewing relevant literature and gov-
ernment publications. Then copies of Delphi-type questionnaires were sent to
TABLE 1
List of experts to whom Delphi questionnaire was sent1
Dr. Michael DeBakey
College of Medicine
Baylor University
Houston, Texas
Dr. P. L. Blackshear
Department of Mechanical Engineering
Institute of Technology
University of Minnesota
Minneapolis, Minnesota
Dr. T. Akutsu
Department of Surgery
University of Mississippi Medical Center
Jackson, Mississippi
Dr. V. L. Gott
Department of Surgery
School of Medicine
Johns Hopkins University
Baltimore, Maryland
Dr. Cominge Liotta
Texas Heart Institute
Texas Medical Center
Houston, Texas
Dr. Y. Nese
Department of Artificial Organs
Cleveland Clinic Foundation
9500 Euclid
Cleveland, Ohio
Dr. C. S. Kwan-Gett
Division of Artificial Organs
Department of Surgery
College of Medicine
University of Utah
Salt Lake City, Utah
Dr. L. T. Harmison
National Heart & Lung Institute
NOTE: It is not to be construed that these are the only or the main experts in this area, but
only that it was these particular individuals that were solicited to participate in this
survey as experts in the area of heart research
xOf these 15 experts, 9 responded, but because the replies were anonymous, the identities
of the nine respondents are not known.
fifteen experts in the area of heart research. These persons were asked to respond
anonymously. (The Delphi technique involves the use of a questionnaire which
is designed to enable a forecast to be made as the result of the systematic solicita-
tion of expert opinion.) Nine of the fifteen experts solicited are shown in table 1.
Because the questionnaires were not marked in any way and because the replies
Med. Services Applications Br.
9000 Rockville Pike
Bethesda, Maryland
Dr. F. N. Huffman
Therme Electron Research and
Development Center
85 First Avenue
Waltham, Mass.
Dr. A. Kantrowitz
Department of Surgery
Maimonides Medical Center
4802 Tenth Avenue
Brooklyn, New York
Dr. Richard R. Lower
Department of Surgery
The Medical College of Virginia
Richmond, Virginia
Dr. Denton A. Cooley
Texas Heart Institute
Texas Medical Center
Houston, Texas
Dr. Frank Hastings
Artificial Heart Program
National Heart and Lung Institute
9000 Rockville Pike
Bethesda, Maryland
Dr. Willem Kolff
Division of Artificial Organs
College of Medicine
University of Utah
Salt Lake City, Utah
Dr. Donald Lyman
University of Utah
Salt Lake City, Utah
348 H. W. LANFORD, F. A. STICKNEY, AND JOHN S. VASKO, M.D. Vol. 73
were anonymous, as requested, the identities of the nine who responded are not
known. Replies are summarized in table 2.
John S. Vasko, M.D., University Hospital, The Ohio State University, Colum-
bus, Ohio, provided extensive expert medical opinion and analysis. He is inti-
mately involved in the field of heart surgery and is familiar with the implications
for utilization of an artificial heart. Because of the extent of his contributions,
Dr. Vasko agreed to be listed as a coauthor of this paper.
Review and analysis of a subject like the development and use of an artificial
heart is highly subjective at this time and does not necessarily produce statistically
reliable conclusions because of the inherent nature of this subject area. However,
it is still very important to review the nature and status of the various factors, as
best determined from the above sources, in order to recognize and understand
how they may affect the utilization of the artificial heart. The analysis of these
factors, plus advance planning, will enable an earlier utilization of the artificial
heart than would be possible if no planning were done until the time when the
artificial heart is finally perfected.
TABLE 2
Summary of responses of respondents participating in Delphi questionnaire survey1
DELPHI QUESTIONNAIRE
The permanent, implantable, totally artificial heart
1. In your opinion when will an implantable internal power source be available that is suitable
for use with the artificial heart and
a. will give approximately 1 year of service?
(1) already has been developed.
5 (2) within the next 5 years.
3 (3) within the next 10 years.
(4) within the next 15 years.
(5) will never be developed.
(6) other (please specify)
b. will give 10 years or more of service?
(1) already has been developed.
(2) within the next 5 years.
4 (3) within the next 10 years.
4 (4) within the next 15 years.
(5) will never be developed.
(6) other (please specify)
2. When do you feel an acceptable antithrombogenic material will be developed and refined
to such a degree that it could be used in the artificial heart and
a. give 1 year of service?
3 (1) already has been developed.
4 (2) within the next 5 years.
2 (3) within the next 10 years.
(4) within the next 15 years.
(5) will never be developed.
(6) other (please specify)
b. give 10 years or more of service?
(1) already has been developed.
1 (2) within the next 5 years.
4 (3) within the next 10 years.
3 (4) within the next 15 years.
(5) will never be developed.
(6) other (please specify).
3. In your opinion when will a temporary heart-assist device that can aid circulation for up
to three months be developed?
4 (1) already has been developed.
5 (2) within the next 5 years.
(3) within the next 10 years.
(4) within the next 15 years.
(5) will never be developed.
(6) other (please specify)
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TABLE 2—(Continued)
DELPHI QUESTIONNAIRE
The permanent, implantable, totally artificial heart
4. In your opinion when will an artificial heart be developed and put into use that will have a
95% reliability and
a. will give 1 year of service?
(1) already has been developed.
5 (2) within the next 5 years.
2 (3) within the next 10 years.
2 (4) within the next 15 years.
(5) will never be developed.
(6) other (please specify) .
b. will give 10 years or more of service?
(1) already has been developed.
1 (2) within the next 5 years.
3 (3) within the next 10 years.
5 (4) within the next 15 years.
(5) will never be developed.
(6) other (please specify).
5. Using 1973 dollars, please estimate the cost of implantation of a permanent totally artificial
heart in the 100th patient to receive such a device.
(1) less than $3000.
(2) $3000-$5000.
3 (3) $5000-110,000.
5 (4) $10,000-$20,000.
1 (6) other (please specify) .
6. What % of individuals in the U.S. dying from heart disease each year could have their
lives prolonged using the totally artificial heart (permanent) ?
3 (1) less than 10%.
2 (2)ll%-20%.
1 (3)21%-40%.
1 (4) 41%-60%.
2 (5)61%-80%.
(6) 81%-100%.
7. Do you think that the federal government will develop a national health program that
would provide this device at a nominal charge to the public?
8 (1) yes. If yes, in what year would such a program be in operation? 1980's.
1 (2) no.
8. Do you personally think that devices such as this one will ever outperform (in terms of
number of malfunctions, estimated length of service) the natural organ it replaces?
2 (1) yes. If yes, in what year would this be achieved? 1977, 1993.
7 (2) no.
9. In your opinion, will use of the artificial heart ever completely replace the use of human
transplants ?
3 (1) yes. If yes, in what year do you think this will occur? 1974, 1985.
5 (2) no.
lK systematic tabulation of the responses of the 9 experts, out of the 15 solicited, who
responded anonymously to the questionnaire.
RESULTS AND DISCUSSION
The future availability of a reliable artificial heart is not totally agreed upon
by experts in the field, probably because of the large amount of research remaining
and the funding still required for this research. Responses to question 4 in the
Delphi questionnaire (table 2) do indicate that all nine respondents believe that
an artificial heart with a 95 percent reliability factor which will give 10 years or
more of service will be available within the next 15 years, although four of them
feel it will be available sooner. The reality of an artificial heart in the future is a
"fact of life" according to Dr. Vasko, and he concurs with the the respondents
to the survey that it will indeed be available within 15 years. However, he
recognizes that extensive research and development are still required in the areas
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of materials, autoregulation, power source, reliability, durability, and the size of
the whole artificial heart. In addition, after it becomes available, Dr. Vasko
feels that there will first be a period of limited use, followed by gradual expansion
of use through controlled clinical trials.
The demand for artificial hearts during the next 15 to 20 years and beyond is
extremely difficult to estimate, because of potential progress that may take place
in medical technology that is unknown at this time. For example, Dr. Vasko
feels that a significant decrease in the incidence of congenital heart lesions is
occurring at the present time, and that some progress is being made in the reduc-
tion of degenerative heart disease. The use of pacemakers and the application of
coronary-artery-bypass graft procedures are other techniques which have the poten-
tial of reducing the demand for the artificial heart. Further development of pre-
ventive medicine may significantly reduce arteriosclerosis and various cardio-
mypathies (the cardiac-muscle disorder usually produced by infectious processes
or autoimmune reactions); this might also reduce the demand for artificial hearts.
The population of the United States in 1971 was 207,049,000 persons, and
estimates indicate an increase to 322,000,000 by the year 2000 (Statistical Abstract
of the United States, 1972). Therefore, the potential decrease in the number of
deaths caused by heart disease, as discussed above, may be offset by the growth
in population; i.e., more individuals may require an artificial heart for survival
as the total population size rises. Other potential factors affecting demand may
become known by the time the artificial heart is perfected and implant and per-
formance experience is obtained. Dr. Vasko feels that the implant of an artificial
heart will be a simpler surgical procedure than are many present heart operations.
Therefore the use of artificial hearts with proven high reliability may be preferable
to other more complex surgical procedures.
The use of an artificial heart implant will have to be evaluated on the basis
of the cost of the procedure compared to the cost of alternative procedures (a cost-
benefit type of analysis). Although the cost is difficult to estimate with any
reliability, Cooper (1972) estimated the cost of an artificial heart to be between
$5,000 and $6,000 and the cost of the implant operation to be from $5,000 to
$50,000. Dr. Vasko, however, feels that the cost of the implant operation would
be less than Cooper's estimate because of the simpler surgical technique involved.
A significant increase in the Federal government's support of medical care is
reflected in the Standard and Poor Industrial Survey (1973), a trend that can be
expected to continue in our present social environment. The U.S. Industrial
Outlook (U.S. Government Printing Office, 1972) estimates that the gross na-
tional product will be 1,400 billion dollars in 1975 and nearly 2,000 billion dollars
in 1980; the authors estimate that it will be approximately 3,000 billion dollars
by the year 2000. All of these estimates are in current dollars. In addition, as
the Gross National Product rises along with population growth, the authors pre-
dict, on the basis of the availability of a higher tax base and society's increasing
demand for medical care for all, still further Federal government participation in
health care. Obviously, there will be compromises between the types of care that
will be available and the mechanisms (types of national health-insurance plans)
used to finance this concept. But the expense of an artificial heart implant, where
required for a patient's survival and return to an acceptable life style, becomes less
important when survival is considered. When a reliable artificial heart is avail-
able, the authors feel strongly that those requiring it will be able to receive the
implant operation, regardless of personal finances.
Another major factor in the utilization of artificial hearts will be the avail-
ability of surgeons to perform the implant operations. The number of physicians
in the United States from 1963 through 1969 is shown in table 3. Using these
data, a least-squares straight-line trend was estimated for the years 1970 through
1975. Based on this, it was calculated that the number of available physicians
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TABLE 3
Number of physicians in the United States
Year
1963
1964
1965
1966
1967
1968
1969
Number1
289,200
297,100
305,100
313,600
322,000
Data not available
338,400
bounded to nearest hundred. Data from
Statistical Abstract of the U.S. (1968, table
86, p. 66, and table 95, p. 68).
would increase by 8,240 each year (table 4). However, the percent of growth,
using this projection, will decrease, unless there is a rise in the absolute number
8 240
of trained physicians, i.e., the growth rate in 1969 was ' or 2.4 percent whereas
the growth rate predicted for 1975 is projected to be ' or only 2.1 percent.
o87,800
Although this suggests a decrease in the rate of increase in the number of phy-
sicians, the authors see no basis, at present, to predict a shortage of qualified
surgeons, especially when the increasing use of highly specialized medical-care
delivery centers and the potential advancements in medical technology are
considered.
TABLE 4
Estimated number of physicians in the
United States
Year
1970
1971
1972
1973
1974
1975
Number
346,600
354,900
363,100
371,400
379,600
387,800
bounded to nearest hundred. Estimates
calculated by least-squares straight-line-
trend technique.
Dr. Vasko predicts that there is and will continue to be a shift to the use of
large heart medical centers which are designed to provide more efficient delivery
of highly specialized heart care. Although he has noted a decline in the number
of surgeons being trained in cardiothoracic specialties, he feels that the use of highly
specialized health-care delivery facilities for heart surgery offsets this decline in
cardiothoracic surgeons. Such specialized facilities better utilize the capabilities
of present and future surgeons; i.e., one heart surgeon can provide more service in
a highly specialized facility than he could in an unspecialized facility. If the
demand for artificial heart implant surgery were added to the present demands
for heart and other surgery, there might be a tendency to predict a shortage of
qualified surgeons. However, the authors feel that this shortage is not probable
unless there is a significant downward change in the trend of available physicians
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and surgeons, as previously discussed. Because the supply of surgeons versus the
demands for their skill is extremely critical to a modern health-delivery-care system,
this should be a subject for periodic review.
Another major factor affecting the future demand for surgeons will be advance-
ments in medical technology. Dr. Vasko predicts that the total demand for sur-
gery and surgeons will decrease as a result of advancements made in medical
technology; such advancements will direct the emphasis toward preventive medi-
cine rather than toward surgery. An example of this is the significant decrease
in the requirement for tuberculosis surgery within recent years. Dr. Vasko feels
that the demand for surgeons will decrease even more significantly when a cure
for cancer is available. Qualified surgeons can then easily be trained to perform
surgery for the implant of artificial hearts.
Medical facilities are another critical factor in the utilization of artificial hearts.
Today there is a trend toward highly specialized and very expensive medical
facilities, which will have a much higher utilization rate than most of the present
medical facilities. Most hospital surgical facilities operate on a schedule from
8 a.m. to 4 p.m., with only emergencies handled at other times. The capability
to expand surgical capacity exists simply by adding multiple shifts (assuming the
availability of qualified staff). Another alternative for increasing capacity is to
have several surgical teams trained and available to support one surgeon. The
time and expense required to train and develop a supporting surgical team is much
less than that required to train and develop an experienced surgeon. Instead of
having long time intervals between surgical operations while operating rooms and
supporting teams are prepared, the operating surgeon could immediately proceed
to another operation if the additional surgical teams were available. With suf-
ficient planning and organization, added surgical capability (surgeons, supporting
team, facilities) for delivery of more health care could rapidly be made available
to meet the demand.
SUMMARY AND CONCLUSIONS
Technological forecasting procedures have been used to estimate trends in
future population size, in the future availability of physicians and surgeons, and
in future facilities. These are three key factors which are highly relevant to the
utilization of the artificial heart in mankind. These estimates reflect no major
problem. If there is a change in any of the factors discussed in this paper, a
reassessment must be made, because of the long lead times required to have avail-
able, when needed, sufficient resources, particularly trained and experienced
surgeons, other supporting personnel, and to a lesser extent, adequate facilities.
It is the opinion of the authors, and also of the nine respondents to the Delphi
questionnaire, that there will be both an artificial heart and implant procedures
available in the future, most likely within the next twenty years. Because a
certain proportion of heart patients in the future will survive only by implanta-
tion of an artificial heart, research and analysis should begin now by analyzing
present heart cases to identify those for whom artificial hearts might have greater
benefit than present heart-surgery methods, either presently available or predicted.
It must be recognized that the artificial heart is not a therapeutic panacea for all
heart disease; other methods of treatment might be developed which are superior
in some cases. Knowledge and experience should be gained so as to identify
cases where implantation of an artificial heart will produce the greatest benefit.
This could aid in reducing the period of controlled clinical trial when the artificial
heart becomes a reality.
By the time a reliable artificial heart is available, the authors conclude that
there will be an adequate demand, a supply of competent surgeons to perform
the implant operation, appropriate facilities of a highly specialized nature, and
funds available through some type of individual and/or government-sponsored
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medical-insurance plan to cover the costs of the operation. The critical factor
now is the allocation of sufficient funds and effort to insure continued progress in
the research and development of the artificial heart itself for benefit of mankind
and to encourage medical doctors and surgeons to study in these directions.
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